FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4286721844> ?p ?o ?g. }

• W4286721844 endingPage "1341" @default.
• W4286721844 startingPage "1336" @default.
• W4286721844 abstract "Although secondary cardiovascular prevention is a focus among patients with type 2 diabetes (T2D) and coronary artery disease (CAD) or peripheral artery disease (PAD), the application of guideline-recommended therapy in T2D patients and isolated cerebrovascular disease (CeVD) remains unknown.In a US outpatient registry, T2D patients with established cardiovascular disease from 2014-2018 were categorized as: isolated CeVD, CeVD plus CAD or PAD, or isolated CAD/PAD. In each group, we determined the proportion with optimal secondary prevention (hemoglobin [Hb]A1C <8%, blood pressure <130/80 mm Hg, use of antithrombotics, use of statins, non-smoking/cessation counseling, and use of glucose-lowering medications with cardioprotective effects (sodium-glucose cotransporter [SGLT]-2 inhibitors, glucagon-like peptide [GLP]-1 receptor agonists, thiazolidinediones [TZDs]). Hierarchical Poisson regression was used to estimate relative rate of achieving each target across groups, adjusted for age and chronic kidney disease (where relevant).Our study included 727,467 T2D outpatients with cardiovascular disease (isolated CeVD [n = 99,777], CeVD plus CAD/PAD [n = 158,361], isolated CAD/PAD [n = 469,329]). Compared with isolated CAD/PAD patients, isolated CeVD patients more often had an HbA1c <8% (adjusted relative risk [aRR] 1.10; 95% confidence interval [CI], 1.08-1.11) but less often had a blood pressure of ≤130/80 mm Hg (aRR 0.93; 95% CI, 0.92-0.94) or were prescribed antithrombotics (0.84; 95% CI, 0.83-0.85), statins (0.86; 95% CI, 0.85-0.87), GLP-1 agonists (0.75; 95% CI, 0.73-0.78), SGLT2 inhibitors (0.73; 95% CI, 0.71-0.76), and TZDs (aRR 0.76; 95% CI, 0.73-0.78).Among T2D patients, those with isolated CeVD had the lowest rates of secondary cardiovascular prevention goals attainment. More focus is needed on secondary prevention in patients with CeVD." @default.
• W4286721844 created "2022-07-23" @default.
• W4286721844 creator A5029175176 @default.
• W4286721844 creator A5036864965 @default.
• W4286721844 creator A5051212717 @default.
• W4286721844 creator A5052311168 @default.
• W4286721844 creator A5060465607 @default.
• W4286721844 creator A5070928171 @default.
• W4286721844 creator A5083393697 @default.
• W4286721844 date "2022-11-01" @default.
• W4286721844 modified "2023-10-16" @default.
• W4286721844 title "Quality of Care Among Patients with Diabetes and Cerebrovascular Disease. Insights from The Diabetes Collaborative Registry" @default.
• W4286721844 cites W1973153166 @default.
• W4286721844 cites W2053806803 @default.
• W4286721844 cites W2118876291 @default.
• W4286721844 cites W2124247204 @default.
• W4286721844 cites W2146264128 @default.
• W4286721844 cites W2151295407 @default.
• W4286721844 cites W2151916231 @default.
• W4286721844 cites W2171165037 @default.
• W4286721844 cites W2274836352 @default.
• W4286721844 cites W2403695849 @default.
• W4286721844 cites W2604277961 @default.
• W4286721844 cites W2626446274 @default.
• W4286721844 cites W2748201042 @default.
• W4286721844 cites W2789529434 @default.
• W4286721844 cites W2789744550 @default.
• W4286721844 cites W2900413769 @default.
• W4286721844 cites W2954229159 @default.
• W4286721844 cites W2974260792 @default.
• W4286721844 cites W3036179581 @default.
• W4286721844 cites W3037508799 @default.
• W4286721844 cites W3090787031 @default.
• W4286721844 cites W3092379111 @default.
• W4286721844 doi "https://doi.org/10.1016/j.amjmed.2022.06.016" @default.
• W4286721844 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35872090" @default.
• W4286721844 hasPublicationYear "2022" @default.
• W4286721844 type Work @default.
• W4286721844 citedByCount "1" @default.
• W4286721844 countsByYear W42867218442023 @default.
• W4286721844 crossrefType "journal-article" @default.
• W4286721844 hasAuthorship W4286721844A5029175176 @default.
• W4286721844 hasAuthorship W4286721844A5036864965 @default.
• W4286721844 hasAuthorship W4286721844A5051212717 @default.
• W4286721844 hasAuthorship W4286721844A5052311168 @default.
• W4286721844 hasAuthorship W4286721844A5060465607 @default.
• W4286721844 hasAuthorship W4286721844A5070928171 @default.
• W4286721844 hasAuthorship W4286721844A5083393697 @default.
• W4286721844 hasConcept C126322002 @default.
• W4286721844 hasConcept C134018914 @default.
• W4286721844 hasConcept C141071460 @default.
• W4286721844 hasConcept C142724271 @default.
• W4286721844 hasConcept C2777180221 @default.
• W4286721844 hasConcept C2778213512 @default.
• W4286721844 hasConcept C2778848681 @default.
• W4286721844 hasConcept C2780182762 @default.
• W4286721844 hasConcept C555293320 @default.
• W4286721844 hasConcept C71924100 @default.
• W4286721844 hasConcept C84393581 @default.
• W4286721844 hasConceptScore W4286721844C126322002 @default.
• W4286721844 hasConceptScore W4286721844C134018914 @default.
• W4286721844 hasConceptScore W4286721844C141071460 @default.
• W4286721844 hasConceptScore W4286721844C142724271 @default.
• W4286721844 hasConceptScore W4286721844C2777180221 @default.
• W4286721844 hasConceptScore W4286721844C2778213512 @default.
• W4286721844 hasConceptScore W4286721844C2778848681 @default.
• W4286721844 hasConceptScore W4286721844C2780182762 @default.
• W4286721844 hasConceptScore W4286721844C555293320 @default.
• W4286721844 hasConceptScore W4286721844C71924100 @default.
• W4286721844 hasConceptScore W4286721844C84393581 @default.
• W4286721844 hasFunder F4320307770 @default.
• W4286721844 hasIssue "11" @default.
• W4286721844 hasLocation W42867218441 @default.
• W4286721844 hasLocation W42867218442 @default.
• W4286721844 hasOpenAccess W4286721844 @default.
• W4286721844 hasPrimaryLocation W42867218441 @default.
• W4286721844 hasRelatedWork W1563850031 @default.
• W4286721844 hasRelatedWork W2003938723 @default.
• W4286721844 hasRelatedWork W2047967234 @default.
• W4286721844 hasRelatedWork W2108606693 @default.
• W4286721844 hasRelatedWork W2152361908 @default.
• W4286721844 hasRelatedWork W2439875401 @default.
• W4286721844 hasRelatedWork W2740237586 @default.
• W4286721844 hasRelatedWork W3009589838 @default.
• W4286721844 hasRelatedWork W4236385187 @default.
• W4286721844 hasRelatedWork W4249487090 @default.
• W4286721844 hasVolume "135" @default.
• W4286721844 isParatext "false" @default.
• W4286721844 isRetracted "false" @default.
• W4286721844 workType "article" @default.